These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 10872719)
1. Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review. Boyce TG; Poland GA Biomed Pharmacother; 2000 May; 54(4):210-8. PubMed ID: 10872719 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B; Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278 [TBL] [Abstract][Full Text] [Related]
3. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577 [TBL] [Abstract][Full Text] [Related]
4. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348 [TBL] [Abstract][Full Text] [Related]
5. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD; Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279 [TBL] [Abstract][Full Text] [Related]
6. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults. Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645 [TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM; Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199 [TBL] [Abstract][Full Text] [Related]
11. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age. Vesikari T; Karvonen A; Smith HM; Dunning A; Razmpour A; Saville MK; Gruber WC; Forrest BD Pediatrics; 2008 Mar; 121(3):e568-73. PubMed ID: 18299305 [TBL] [Abstract][Full Text] [Related]
12. Emerging data on the safety and efficacy of influenza vaccines in children. Vesikari T Pediatr Infect Dis J; 2008 Nov; 27(11 Suppl):S159-61. PubMed ID: 18955892 [TBL] [Abstract][Full Text] [Related]
14. Live attenuated influenza vaccine in children. Ambrose CS; Walker RE; Connor EM Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372 [TBL] [Abstract][Full Text] [Related]
15. Universal influenza vaccination and live attenuated influenza vaccination of children. Glezen WP Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568 [TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China. Zhu FC; Zhou W; Pan H; Lu L; Gerez L; Nauta J; Giezeman K; de Bruijn I Vaccine; 2008 Aug; 26(35):4579-84. PubMed ID: 18602729 [TBL] [Abstract][Full Text] [Related]
17. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years. Belshe RB; Nichol KL; Black SB; Shinefield H; Cordova J; Walker R; Hessel C; Cho I; Mendelman PM Clin Infect Dis; 2004 Oct; 39(7):920-7. PubMed ID: 15472840 [TBL] [Abstract][Full Text] [Related]